Schering-Plough
This article was originally published in The Rose Sheet
Executive Summary
CEO Richard Kogan elected chairman of the board, succeeding Robert Luciano, the company announced Sept. 25. Luciano will remain a member of the board. Raul Cesan, another newly elected board member, will assume Kogan's responsibilities as president, as well as add chief operating officer to his title. Cesan advances from Schering-Plough Pharmaceuticals president and corporate exec VP. Both appointments are effective Nov. 1